HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Yatomi Selected Research

Lysophosphatidylcholines (Lysophosphatidylcholine)

1/2022Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease.
11/2019Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
1/2019Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry.
1/2018Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
1/2018Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.
1/2018Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study.
12/2013Inhibition of lysophosphatidic acid increase by prestorage whole blood leukoreduction in autologous CPDA-1 whole blood.
11/2007Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
7/2007Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Yatomi Research Topics

Disease

40Neoplasms (Cancer)
04/2022 - 11/2004
15Fibrosis (Cirrhosis)
12/2021 - 04/2006
14Inflammation (Inflammations)
01/2021 - 10/2008
13Hepatocellular Carcinoma (Hepatoma)
04/2020 - 10/2011
12Liver Cirrhosis (Hepatic Cirrhosis)
03/2019 - 09/2007
11Acute Coronary Syndrome
09/2019 - 12/2011
10COVID-19
04/2022 - 01/2021
9Atherosclerosis
12/2019 - 11/2010
8Hypertension (High Blood Pressure)
11/2020 - 09/2007
8Neoplasm Metastasis (Metastasis)
10/2017 - 01/2006
7Diabetic Nephropathies (Diabetic Nephropathy)
12/2022 - 01/2010
6Lymphoma (Lymphomas)
08/2022 - 10/2008
6Glaucoma
06/2021 - 01/2018
6Obesity
01/2021 - 12/2013
6Thrombosis (Thrombus)
01/2020 - 08/2010
6Liver Diseases (Liver Disease)
01/2018 - 11/2009
6Chronic Hepatitis C
01/2018 - 07/2007
6Stomach Neoplasms (Stomach Cancer)
10/2017 - 11/2004
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 12/2011
5Infections
02/2022 - 06/2011
5Melanoma (Melanoma, Malignant)
02/2021 - 07/2007
5Wounds and Injuries (Trauma)
01/2021 - 01/2007
5Hemorrhage
12/2020 - 08/2005
5Colonic Neoplasms (Colon Cancer)
01/2020 - 02/2015
4Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 11/2012
4Autoimmune Diseases (Autoimmune Disease)
08/2022 - 01/2011
4Heart Failure
10/2021 - 07/2012
4Diabetes Mellitus
07/2021 - 07/2018
4Insulin Resistance
01/2021 - 09/2014
4Leukemia
01/2020 - 05/2013
4Adenocarcinoma of Lung
10/2018 - 06/2017
4Body Weight (Weight, Body)
02/2018 - 03/2009
4Stable Angina
09/2017 - 11/2012
4Thrombocytopenia (Thrombopenia)
06/2017 - 08/2010
4Lung Neoplasms (Lung Cancer)
09/2014 - 12/2009
3Type 2 Diabetes Mellitus (MODY)
12/2022 - 02/2009
3Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2021 - 01/2021
3Disease Progression
09/2021 - 01/2013
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 11/2012
3Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 11/2018
3Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 07/2013
3Chronic Renal Insufficiency
01/2019 - 07/2018
3Non-alcoholic Fatty Liver Disease
07/2018 - 10/2011
3Hepatitis C
07/2018 - 06/2011
3Fatty Liver
02/2018 - 08/2009
3Vascular Diseases (Vascular Disease)
09/2017 - 12/2002

Drug/Important Bio-Agent (IBA)

37Biomarkers (Surrogate Marker)IBA
04/2022 - 06/2006
23LipidsIBA
12/2022 - 04/2002
22sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 04/2003
21lysophosphatidic acidIBA
10/2020 - 09/2006
20Messenger RNA (mRNA)IBA
01/2020 - 09/2007
15LysophospholipidsIBA
01/2022 - 04/2003
15EnzymesIBA
01/2022 - 07/2007
12AntigensIBA
08/2022 - 08/2005
11AlbuminsIBA
04/2022 - 01/2017
11Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2007
10SphingosineIBA
12/2022 - 01/2007
9Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2022 - 07/2007
8lysophosphatidylserineIBA
04/2020 - 10/2014
7AntibodiesIBA
02/2022 - 02/2011
7Immunoglobulin M (IgM)IBA
02/2022 - 08/2013
7Phospholipases A1 (Phospholipase A1)IBA
02/2021 - 01/2017
7PhosphatidylserinesIBA
02/2021 - 01/2017
7alkylglycerophosphoethanolamine phosphodiesteraseIBA
01/2018 - 07/2006
6Alanine Transaminase (SGPT)IBA
04/2022 - 09/2007
6Immunoglobulin G (IgG)IBA
02/2022 - 01/2021
6SphingolipidsIBA
01/2022 - 04/2002
6Pharmaceutical PreparationsIBA
01/2020 - 08/2010
6Phosphates (Orthophosphate)IBA
01/2020 - 01/2007
5CeramidesIBA
12/2022 - 01/2018
5Protein Isoforms (Isoforms)IBA
01/2022 - 05/2013
5Biological ProductsIBA
01/2021 - 12/2002
5Indicators and Reagents (Reagents)IBA
04/2020 - 02/2012
5Hyaluronic Acid (Hyaluronan)IBA
01/2020 - 05/2010
5MicroRNAs (MicroRNA)IBA
10/2018 - 12/2011
5Choline (Choline Chloride)IBA
01/2018 - 07/2007
5Sphingosine-1-Phosphate ReceptorsIBA
09/2014 - 01/2006
4oxidized low density lipoproteinIBA
12/2022 - 11/2010
4CholesterolIBA
07/2021 - 11/2010
4mercaptoalbuminIBA
01/2021 - 01/2018
4SaltsIBA
11/2020 - 05/2011
4LyasesIBA
01/2020 - 12/2013
4Carbon Tetrachloride (Tetrachloromethane)IBA
05/2010 - 09/2007
3HDL LipoproteinsIBA
12/2022 - 01/2016
3Triglycerides (Triacylglycerol)IBA
12/2022 - 02/2015
3Hexosaminidases (Hexosaminidase)IBA
04/2022 - 03/2020
3Immunoglobulin A (IgA)IBA
02/2022 - 01/2019
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2022 - 02/2011
3Fibrinogen (Factor I)FDA Link
04/2021 - 06/2006
3LipopolysaccharidesIBA
01/2021 - 01/2015
3Lysophosphatidic Acid ReceptorsIBA
01/2021 - 08/2013
3CytokinesIBA
01/2021 - 11/2010
3Serum AlbuminIBA
01/2021 - 11/2018
3Hemostatics (Antihemorrhagics)IBA
12/2020 - 01/2018
3Insulin (Novolin)FDA Link
01/2020 - 02/2009
3Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2019 - 10/2008
3Hemoglobins (Hemoglobin)IBA
11/2018 - 05/2010
3Phosphotransferases (Kinase)IBA
01/2018 - 01/2016

Therapy/Procedure

12Therapeutics
01/2021 - 01/2007
4Drug Therapy (Chemotherapy)
01/2018 - 08/2013